A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases

by Mottaghi-Dastjerdi, N., Raad, M.S.R, Sharifzadeh, M.
Published 2022

ER Stress in COVID-19 and Parkinson’s Disease: In Vitro and In Silico Evidences

by Ahmed, B.Y, Chaudhry, Z.L, Ferhati, I., Gamal, M., Warda, M.
Published 2022

Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV

by Denessiouk, K., Denesyuk, A.I, Johnson, M.S, Permyakov, E.A, Permyakov, S.E, Uversky, V.N
Published 2021

Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease

by Chen, K., Chen, X., Fang, L., Lei, Y., Ma, Y., Pan, J., Tang, J., Xu, W., Xu, Y., Zhan, J., Zhang, B., Zhang, D., Zheng, Y., Zhou, Y.
Published 2021

Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca

by Alsfouk, A.A, Dehaen, W., Eissa, I.H, Elkaeed, E.B, Ishmuratova, M.Y, Jose, R.A, Metwaly, A.M, Suleimen, R.N, Suleimen, Y.M, Toppet, S.
Published 2022

Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca

by Alsfouk, A.A, Dehaen, W., Eissa, I.H, Elkaeed, E.B, Ishmuratova, M.Y, Jose, R.A, Metwaly, A.M, Suleimen, R.N, Suleimen, Y.M, Toppet, S.
Published 2022

The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties

by Dobrucki, J., Greb-Markiewicz, B., Kolonko-Adamska, M., Ożyhar, A., Tarczewska, A., Zarębski, M.
Published 2021

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro

by Chen, H., Chen, L., Ge, G., Hu, Q., Li, C., Wang, H., Wang, M., Wang, R., Zhang, Q., Zhang, Y., Zhao, Y., Zhu, G.
Published 2021

Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review

by Abdelmaksoud, A., Dursun, R., Goldust, M., Kutlu, O., Lotti, T., Patil, A., Temiz, S.A, Vestita, M., Wollina, U.
Published 2022

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study

by Blumenthal, K., Chamberlin, G., Damsky, W., Desai, S.R, Fathy, R., Fox, L.P, Freeman, E.E, French, L.E, Hruza, G.J, Kovarik, C.L, Lim, H.W, Lipoff, J.B, McMahon, D.E, Nazarian, R.M, Rosenbach, M., Thiers, B.H, Tyagi, A.
Published 2022

Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches

by Cho, K.-H, Choi, P., Ham, J., Kim, T., Lee, J., Park, J.G, Raj, V.
Published 2021

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

by Alsaadawe, M., Chen, X., Chen, Z., Disoma, C., Dong, Z., Du, A., Hu, L., Jiang, T., Li, S., Li, S., Li, S., Liu, P., Liu, S., Mo, L., Peng, J., Peng, Y., Razzaq, A., Shen, Y., Xia, Z., Yang, Q., Zhang, Q., Zhang, Y., Zheng, R., Zhou, Y.
Published 2021

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19

by Chang, A., Yu, J.
Published 2022